Voloridge Investment Management, LLC Apellis Pharmaceuticals, Inc. Transaction History

Voloridge Investment Management, LLC

$26.2 Billion
Q3 2024

A detailed history of Voloridge Investment Management, LLC transactions in Apellis Pharmaceuticals, Inc. stock. As of the latest transaction made, Voloridge Investment Management, LLC holds 814,564 shares of APLS stock, worth $27 Million. This represents 0.09% of its overall portfolio holdings.

Number of Shares

814,564

Previous 689,108 18.21%

Holding current value

$27 Million

Previous $26.4 Million 11.13%

% of portfolio

0.09%

Previous 0.1%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$28.84 - $41.15 $3.62 Million - $5.16 Million	125,456 Added 18.21%	814,564 $23.5 Million
Q2 2024 Aug 14, 2024	BUY	$38.07 - $59.71 $26.2 Million - $41.1 Million	689,108 New	689,108 $26.4 Million
Q3 2023 Nov 14, 2023	SELL	$23.65 - $89.22 $2.11 Million - $7.95 Million	-89,139 Reduced 62.16%	54,263 $2.06 Million
Q2 2023 Aug 14, 2023	BUY	$76.68 - $93.31 $5.92 Million - $7.2 Million	77,167 Added 116.5%	143,402 $13.1 Million
Q1 2023 May 15, 2023	BUY	$46.59 - $66.96 $3.09 Million - $4.44 Million	66,235 New	66,235 $4.37 Million
Q3 2022 Nov 14, 2022	BUY	$44.76 - $69.66 $4.81 Million - $7.49 Million	107,452 New	107,452 $7.34 Million
Q2 2022 Aug 15, 2022	SELL	$35.07 - $59.21 $2.58 Million - $4.35 Million	-73,426 Closed	0 $0
Q1 2022 May 16, 2022	SELL	$35.46 - $54.12 $97,018 - $148,072	-2,736 Reduced 3.59%	73,426 $3.73 Million
Q4 2021 Feb 14, 2022	SELL	$30.74 - $49.16 $8.38 Million - $13.4 Million	-272,546 Reduced 78.16%	76,162 $3.6 Million
Q3 2021 Nov 15, 2021	BUY	$31.4 - $69.84 $6.09 Million - $13.5 Million	193,909 Added 125.27%	348,708 $11.5 Million
Q2 2021 Aug 16, 2021	BUY	$40.9 - $64.9 $6.33 Million - $10 Million	154,799 New	154,799 $9.78 Million
Q1 2021 May 17, 2021	SELL	$40.8 - $57.39 $322,360 - $453,438	-7,901 Closed	0 $0
Q4 2020 Feb 16, 2021	BUY	$30.79 - $57.2 $243,271 - $451,937	7,901 New	7,901 $452,000
Q1 2020 May 15, 2020	SELL	$17.91 - $44.33 $300,207 - $743,059	-16,762 Closed	0 $0
Q4 2019 Feb 14, 2020	BUY	$22.1 - $30.8 $370,440 - $516,269	16,762 New	16,762 $513,000
Q2 2019 Aug 14, 2019	SELL	$18.0 - $25.34 $212,364 - $298,961	-11,798 Closed	0 $0
Q1 2019 May 15, 2019	BUY	$12.81 - $19.82 $151,132 - $233,836	11,798 New	11,798 $230,000

Others Institutions Holding APLS

# of Institutions

308

Shares Held

115M

Call Options Held

3.85M

Put Options Held

1.09M

View Full List

About Apellis Pharmaceuticals, Inc.

Ticker APLS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 109,865,000
Market Cap $3.64B
Description
Apellis Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of therapeutic compounds through the inhibition of the complement system for autoimmune and inflammatory diseases. The company's lead product candidate is pegcetacoplan that is in Phase III clinical trials for...

More about APLS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Voloridge Investment Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Voloridge Investment Management, LLC with notifications on news.

Account

Voloridge Investment Management, LLC Apellis Pharmaceuticals, Inc. Transaction History